These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28358667)

  • 1. Optimizing SABR delivery for synchronous multiple lung tumors using volumetric-modulated arc therapy.
    Tekatli H; Tetar SU; Nguyen TK; Warner A; Verbakel WF; Palma DA; Dahele M; Gaede S; Haasbeek C; Spoelstra FO; de Haan PF; Slotman BJ; Senan S
    Acta Oncol; 2017 Apr; 56(4):548-554. PubMed ID: 28358667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
    Siva S; Kirby K; Caine H; Pham D; Kron T; Te Marvelde L; Whalley D; Stevens MJ; Foroudi F; MacManus M; Ball D; Eade T
    Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):353-61. PubMed ID: 25698068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases.
    Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U
    Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single fraction spine stereotactic ablative body radiotherapy with volumetric modulated arc therapy.
    Gestaut MM; Thawani N; Kim S; Gutti VR; Jhavar S; Deb N; Morrow A; Ward RA; Huang JH; Patel M
    J Neurooncol; 2017 May; 133(1):165-172. PubMed ID: 28409420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2).
    Deodato F; Cilla S; Macchia G; Torre G; Caravatta L; Mariano G; Mignogna S; Ferro M; Mattiucci GC; Balducci M; Frascino V; Piermattei A; Ferrandina G; Valentini V; Morganti AG
    Clin Oncol (R Coll Radiol); 2014 Dec; 26(12):748-56. PubMed ID: 25175042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors.
    Chaudhuri AA; Tang C; Binkley MS; Jin M; Wynne JF; von Eyben R; Hara WY; Trakul N; Loo BW; Diehn M
    Lung Cancer; 2015 Jul; 89(1):50-6. PubMed ID: 25997421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
    Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
    Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
    Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.
    Senthi S; Lagerwaard FJ; Haasbeek CJ; Slotman BJ; Senan S
    Lancet Oncol; 2012 Aug; 13(8):802-9. PubMed ID: 22727222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
    Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter.
    Helou J; Thibault I; Poon I; Chiang A; Jain S; Soliman H; Erler D; Yeung L; Cheung P
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):419-427. PubMed ID: 28463162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
    Finazzi T; Palacios MA; Spoelstra FOB; Haasbeek CJA; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):933-941. PubMed ID: 30928360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric-modulated arc therapy for stereotactic body radiotherapy of lung tumors: a comparison with intensity-modulated radiotherapy techniques.
    Holt A; van Vliet-Vroegindeweij C; Mans A; Belderbos JS; Damen EM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1560-7. PubMed ID: 21300461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation Therapy.
    Zhao L; Zhou S; Balter P; Shen C; Gomez DR; Welsh JD; Lin SH; Chang JY
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1226-35. PubMed ID: 27209498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A treatment-planning comparison of three beam arrangement strategies for stereotactic body radiation therapy for centrally located lung tumors using volumetric-modulated arc therapy.
    Ishii K; Okada W; Ogino R; Kubo K; Kishimoto S; Nakahara R; Kawamorita R; Ishii Y; Tada T; Nakajima T
    J Radiat Res; 2016 Jun; 57(3):273-9. PubMed ID: 26951076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results.
    Macchia G; Deodato F; Cilla S; Torre G; Corrado G; Legge F; Gambacorta MA; Tagliaferri L; Mignogna S; Scambia G; Valentini V; Morganti AG; Ferrandina G
    Oncol Rep; 2014 Nov; 32(5):2237-43. PubMed ID: 25175950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of arm position on the dosimetry of thoracic stereotactic ablative radiation therapy using volumetric modulated arc therapy.
    Shultz DB; Jang SS; Hanlon AL; Diehn M; Loo BW; Maxim PG
    Pract Radiat Oncol; 2014; 4(3):192-197. PubMed ID: 24766687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors.
    Trakul N; Chang CN; Harris J; Chapman C; Rao A; Shen J; Quinlan-Davidson S; Filion EJ; Wakelee HA; Colevas AD; Whyte RI; Dieterich S; Maxim PG; Hristov D; Tran P; Le QT; Loo BW; Diehn M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):231-7. PubMed ID: 22381907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.
    Takahashi W; Yamashita H; Kida S; Masutani Y; Sakumi A; Ohtomo K; Nakagawa K; Haga A
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):426-31. PubMed ID: 23562767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer.
    Haasbeek CJ; Lagerwaard FJ; Slotman BJ; Senan S
    J Thorac Oncol; 2011 Dec; 6(12):2036-43. PubMed ID: 21892102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.